TD Cowen Says Novartis (NVS) Has Strong Growth Path Through 2029

Novartis AG (NYSE:NVS) ranks among the best dilatory maturation stocks to put in. Following meetings with Novartis AG (NYSE:NVS)’s caput of U.S. operations successful Boston, New York, and San Francisco, TD Cowen reaffirmed its Hold standing connected the company’s shares connected November 10 with a terms people of $140. The meetings revealed a fig of maturation drivers that enactment Novartis’ estimated 6% income CAGR from 2024 to 2029.

lucarista/Shutterstock.com

Existing medicines similar Cosentyx, Pluvicto, Kisqali, Leqvio, Kesimpta, and Scemblix were noted arsenic important maturation contributors and are anticipated to assistance the institution successful overcoming generic erosion challenges, particularly for Entresto.

TD Cowen besides emphasized Novartis’ stronger foothold successful immunology done Rhapsido and ianalumab, which the steadfast termed arsenic “substantially de-risked” fixed caller objective evaluations and poised to lend meaningfully to maturation earlier 2030.

Additionally, connected November 20, the Swiss drugmaker revised its mid-term income people for 2025-2030 to bespeak a CAGR of 5-6% successful changeless currencies. Novartis AG (NYSE:NVS) besides stated that it aims to instrumentality to margins supra 40% by 2029, aft absorbing 1-2 percent points of dilution from the anticipated acquisition of Avidity Biosciences.

Novartis AG (NYSE:NVS) is an innovative medicines company‌ that discove‍rs, deve‍lop⁠s, a​nd manufactures treatments designed to​ improve⁠ and widen lives portion tackling superior diseases.

While we admit the imaginable of NVS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.